Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boulder, CO
SEC filing record 1 source field available
Fiscal year end
31 December
Clovis Oncology, Inc. has filed 952 SEC EDGAR filings since 25 Jun 2009

SEC filing history

Showing 826-850 of 951 matching filings.

Per page
25
Current page
34
SC 13G/A File 005-86488

SCHEDULE 13G AMENDMENT 1

Filing date
14 Feb 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-86488

SC 13G/A filing

Filing date
14 Feb 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
5

FORM 5

Filing date
13 Feb 2013
Reporting date
31 Dec 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-86488

AMENDMENT NO. 1

Filing date
11 Feb 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-86488

SC 13G/A

Filing date
11 Feb 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35347

FORM 8-K

Filing date
09 Jan 2013
Reporting date
07 Jan 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
31 Dec 2012
Reporting date
27 Dec 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35347

CLOVIS ONCOLOGY, INC. 8-K

Filing date
13 Nov 2012
Reporting date
12 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35347

CLOVIS ONCOLOGY, INC. 8-K

Filing date
05 Nov 2012
Reporting date
05 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
16 Aug 2012
Reporting date
14 Aug 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35347

CLOVIS ONCOLOGY, INC. 8-K

Filing date
08 Aug 2012
Reporting date
08 Aug 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-182278

FORM S-8

Filing date
22 Jun 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
18 Jun 2012
Reporting date
14 Jun 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
18 Jun 2012
Reporting date
14 Jun 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

MAIN DOCUMENT DESCRIPTION

Filing date
18 Jun 2012
Reporting date
14 Jun 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35347

FORM 8-K

Filing date
18 Jun 2012
Reporting date
14 Jun 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
18 Jun 2012
Reporting date
14 Jun 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
15 Jun 2012
Reporting date
14 Jun 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
15 Jun 2012
Reporting date
14 Jun 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
15 Jun 2012
Reporting date
14 Jun 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35347

CLOVIS ONCOLOGY, INC. 8-K

Filing date
08 May 2012
Reporting date
08 May 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-35347

DEF 14A

Filing date
27 Apr 2012
Reporting date
14 Jun 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .